| 引用本文:谢鑫，李琳，陈夏.肺脾肾三脏并调疗法对痛风慢性期患者疗效的影响[J].世界中医药,2017,(11):. |
|
| 肺脾肾三脏并调疗法对痛风慢性期患者疗效的影响 |
| Effect of Lung,Spleen,Kidney Co-regulating Therapy in the treatment of Chronic Gout Patients |
| 投稿时间：2017-01-04 |
| DOI：10.3969/j.issn.1673-7202.2017.11.034 |
| 中文关键词: 痛风慢性期 肺脾肾 三脏并调疗法 别嘌醇片 |
| English Keywords:Lung spleen and kidney Co-regulating therapy Chronic gout Curative effect |
| 基金项目:陕西省安康市科技局基金项目(10AK09-07) |
|
| 摘要点击次数: 865 |
| 全文下载次数: 936 |
| 中文摘要: |
| 目的：探讨肺脾肾三脏并调疗法对痛风慢性期患者疗效的影响。方法：选取2012年3月至2016年12月在我院进行治疗的痛风慢性期患者78例纳入本次研究。根据数字表法将78例患者分成观察组以及对照组各含39例，对照组给予基础治疗并口服别嘌醇片，观察组在其基础上使用肺脾肾三脏并调疗法，治疗2周后比较2组疗效，症状评分，尿酸(UA)、尿素氮(BNU)、红细胞沉降率（ESR）、类风湿因子（RF），以及不良反应。结果：观察组治疗有效率是97.44%，均分别明显高于对照组的82.05%，差异有统计学意义（P<0.05）。治疗后2组的关节疼痛和关节肿胀，以及关节屈伸不利的评分均分别明显低于治疗前，且观察组的各项症状评分均明显低于对照组，差异均有统计学意义（均P<0.05）。治疗后2组的UA、BUN、ESR及RF水平均分别明显低于治疗前，且观察组明显低于对照组，差异均有统计学意义（均P<0.05）。观察组不良反应的发生率是7.69%，较对照组的25.64%明显更低，差异有统计学意义（P<0.05）。结论：肺脾肾三脏并调疗法能够有效治疗痛风慢性期患者，且安全性较好。 |
| English Summary: |
| To observe the effect of lung,spleen,kidney co-regulating therapy in the treatment of chronic gout patients.Methods:From March 2014 to December 2016,78 patients with chronic gout were collected,then divided into observation group and control group randomly,each with 39 cases.The control group was given basic treatment and oral administration of Allopurinol Tablets,while the observation group,on the basis of that,used lung and spleen and kidney co-regulating therapy.Symptoms after 2 weeks of treatment,symptom score,biochemical indexes (UA urea nitrogen BNU,uric acid,ESR and ESR rheumatoid factor RF),and adverse reactions were compared between the two groups.Results:The effective rate of the observation group was 51.28%,the total effective rate was 97.44%,which were significantly higher than those of the control group of 25.64% and 82.05%,so the difference is statistically significant (P<0.05).After treatment,two groups of joint pain and joint swelling,and joint flexion and extension adverse scores were significantly lower than before treatment,and the scores of the observation group were significantly lower than the control group (P<0.05).After treatment,the levels of UA,BUN,ESR and RF in the two groups were significantly lower than those before treatment,and the above biochemical indexes in the observation group were significantly lower than those in the control group(P<0.05).The total incidence of adverse reactions in the observation group was 7.69%,significantly lower than the control group of 25.64% (P<0.05).Conclusion:Lung,spleen and kidney co-regulating therapy can effectively treat chronic gout patients.The therapy is effective and worthy of promotion in clinical. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
